Concepts (303)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Vocal Cord Paralysis | 20 | 2025 | 66 | 9.160 |
Why?
|
| Laryngoscopy | 17 | 2024 | 157 | 5.150 |
Why?
|
| Larynx | 11 | 2024 | 72 | 4.760 |
Why?
|
| Vocal Cords | 18 | 2025 | 60 | 4.650 |
Why?
|
| Deglutition Disorders | 11 | 2025 | 138 | 4.510 |
Why?
|
| Dysphonia | 7 | 2025 | 16 | 2.870 |
Why?
|
| Voice Quality | 7 | 2024 | 20 | 2.820 |
Why?
|
| Recurrent Laryngeal Nerve | 5 | 2025 | 9 | 2.670 |
Why?
|
| Tracheostomy | 9 | 2024 | 215 | 2.530 |
Why?
|
| Laryngoplasty | 5 | 2024 | 26 | 2.440 |
Why?
|
| Vocal Cord Dysfunction | 4 | 2022 | 8 | 2.040 |
Why?
|
| Ultrasonography | 5 | 2021 | 933 | 1.870 |
Why?
|
| Tracheal Diseases | 3 | 2024 | 14 | 1.870 |
Why?
|
| Laryngostenosis | 6 | 2023 | 37 | 1.820 |
Why?
|
| Postoperative Complications | 11 | 2024 | 3066 | 1.680 |
Why?
|
| Glottis | 3 | 2023 | 29 | 1.620 |
Why?
|
| Speech | 2 | 2025 | 56 | 1.430 |
Why?
|
| Deglutition | 5 | 2023 | 57 | 1.430 |
Why?
|
| Voice Disorders | 3 | 2018 | 16 | 1.410 |
Why?
|
| Cutaneous Fistula | 2 | 2024 | 21 | 1.370 |
Why?
|
| Laryngeal Diseases | 4 | 2023 | 28 | 1.360 |
Why?
|
| Voice | 3 | 2025 | 16 | 1.250 |
Why?
|
| Tracheotomy | 3 | 2024 | 35 | 1.240 |
Why?
|
| Female | 63 | 2025 | 68330 | 1.210 |
Why?
|
| Male | 59 | 2025 | 62543 | 1.200 |
Why?
|
| Infant | 26 | 2024 | 12771 | 1.180 |
Why?
|
| Retrospective Studies | 36 | 2025 | 17005 | 1.180 |
Why?
|
| Nerve Transfer | 2 | 2025 | 8 | 1.150 |
Why?
|
| Aorta, Thoracic | 3 | 2018 | 535 | 1.140 |
Why?
|
| Child | 38 | 2025 | 25101 | 1.120 |
Why?
|
| Bronchoscopy | 4 | 2021 | 177 | 1.090 |
Why?
|
| Laryngoscopes | 3 | 2022 | 71 | 1.040 |
Why?
|
| Reoperation | 3 | 2024 | 818 | 1.020 |
Why?
|
| Humans | 81 | 2025 | 126754 | 1.020 |
Why?
|
| Tomography, X-Ray Computed | 9 | 2021 | 2039 | 1.010 |
Why?
|
| Laser Therapy | 3 | 2020 | 229 | 0.990 |
Why?
|
| Vagus Nerve Stimulation | 2 | 2024 | 59 | 0.990 |
Why?
|
| Speech Acoustics | 1 | 2025 | 9 | 0.940 |
Why?
|
| Speech Production Measurement | 1 | 2025 | 18 | 0.930 |
Why?
|
| Child, Preschool | 23 | 2025 | 14347 | 0.920 |
Why?
|
| Voice Training | 2 | 2016 | 6 | 0.910 |
Why?
|
| Singing | 2 | 2016 | 9 | 0.910 |
Why?
|
| Airway Obstruction | 4 | 2020 | 175 | 0.900 |
Why?
|
| Cough | 3 | 2025 | 94 | 0.880 |
Why?
|
| Down Syndrome | 2 | 2020 | 200 | 0.880 |
Why?
|
| Recurrent Laryngeal Nerve Injuries | 3 | 2019 | 14 | 0.790 |
Why?
|
| Trachea | 2 | 2024 | 204 | 0.790 |
Why?
|
| Epiglottis | 2 | 2023 | 8 | 0.750 |
Why?
|
| Hypopharynx | 2 | 2025 | 7 | 0.740 |
Why?
|
| Pharyngeal Diseases | 2 | 2025 | 17 | 0.730 |
Why?
|
| Transition to Adult Care | 1 | 2024 | 122 | 0.720 |
Why?
|
| Adolescent | 18 | 2025 | 20002 | 0.690 |
Why?
|
| Macroglossia | 1 | 2020 | 2 | 0.680 |
Why?
|
| Preceptorship | 1 | 2021 | 28 | 0.680 |
Why?
|
| Electromyography | 2 | 2019 | 136 | 0.680 |
Why?
|
| Polyps | 2 | 2023 | 40 | 0.680 |
Why?
|
| Fluoroscopy | 4 | 2021 | 92 | 0.680 |
Why?
|
| Granuloma, Pyogenic | 1 | 2020 | 6 | 0.670 |
Why?
|
| Pharynx | 3 | 2020 | 64 | 0.670 |
Why?
|
| Quality of Life | 5 | 2024 | 2029 | 0.650 |
Why?
|
| Heart Defects, Congenital | 4 | 2021 | 1853 | 0.650 |
Why?
|
| Cerebral Palsy | 1 | 2021 | 80 | 0.640 |
Why?
|
| Laryngeal Nerves | 1 | 2019 | 3 | 0.630 |
Why?
|
| Edema | 2 | 2020 | 137 | 0.630 |
Why?
|
| DiGeorge Syndrome | 1 | 2019 | 79 | 0.600 |
Why?
|
| Peripheral Nerve Injuries | 1 | 2018 | 35 | 0.580 |
Why?
|
| Case-Control Studies | 8 | 2019 | 3314 | 0.580 |
Why?
|
| Prospective Studies | 13 | 2024 | 6214 | 0.580 |
Why?
|
| Croup | 1 | 2018 | 12 | 0.580 |
Why?
|
| Laryngismus | 1 | 2018 | 4 | 0.560 |
Why?
|
| Laryngeal Muscles | 1 | 2018 | 5 | 0.560 |
Why?
|
| Respiratory Tract Diseases | 1 | 2018 | 79 | 0.560 |
Why?
|
| Treatment Outcome | 15 | 2024 | 12546 | 0.560 |
Why?
|
| Respiratory Aspiration | 2 | 2017 | 11 | 0.550 |
Why?
|
| Phonation | 2 | 2021 | 6 | 0.550 |
Why?
|
| Crying | 1 | 2017 | 12 | 0.550 |
Why?
|
| Chondrosarcoma | 1 | 2017 | 13 | 0.540 |
Why?
|
| Respiratory Tract Fistula | 1 | 2017 | 17 | 0.540 |
Why?
|
| Middle Aged | 20 | 2025 | 27697 | 0.530 |
Why?
|
| Smartphone | 1 | 2017 | 44 | 0.530 |
Why?
|
| Zenker Diverticulum | 2 | 2019 | 4 | 0.520 |
Why?
|
| Point-of-Care Systems | 1 | 2019 | 197 | 0.520 |
Why?
|
| Sialadenitis | 1 | 2016 | 1 | 0.520 |
Why?
|
| Device Removal | 2 | 2021 | 220 | 0.510 |
Why?
|
| Laryngeal Neoplasms | 1 | 2017 | 85 | 0.510 |
Why?
|
| Esophageal Diseases | 1 | 2016 | 33 | 0.500 |
Why?
|
| Intraoperative Care | 1 | 2017 | 123 | 0.490 |
Why?
|
| Actinomycosis | 1 | 2016 | 8 | 0.490 |
Why?
|
| Mobile Applications | 1 | 2017 | 108 | 0.480 |
Why?
|
| Thyroid Cartilage | 1 | 2015 | 3 | 0.480 |
Why?
|
| Observer Variation | 4 | 2019 | 305 | 0.470 |
Why?
|
| Ultrasonography, Doppler | 1 | 2016 | 181 | 0.470 |
Why?
|
| Osteochondrodysplasias | 1 | 2015 | 66 | 0.460 |
Why?
|
| Aortic Diseases | 1 | 2017 | 186 | 0.460 |
Why?
|
| Infant, Newborn | 10 | 2023 | 8347 | 0.450 |
Why?
|
| Cardiac Surgical Procedures | 2 | 2021 | 1162 | 0.440 |
Why?
|
| Respiratory Tract Infections | 2 | 2020 | 278 | 0.440 |
Why?
|
| Platelet Aggregation Inhibitors | 1 | 2017 | 275 | 0.440 |
Why?
|
| Tracheal Stenosis | 1 | 2014 | 31 | 0.440 |
Why?
|
| Calcinosis | 1 | 2015 | 184 | 0.420 |
Why?
|
| Larynx, Artificial | 1 | 2013 | 8 | 0.420 |
Why?
|
| Tracheoesophageal Fistula | 1 | 2014 | 48 | 0.420 |
Why?
|
| Education, Professional | 1 | 2013 | 10 | 0.420 |
Why?
|
| Follow-Up Studies | 8 | 2024 | 5114 | 0.410 |
Why?
|
| Hearing Loss, Sensorineural | 3 | 2021 | 155 | 0.410 |
Why?
|
| Stroboscopy | 3 | 2019 | 4 | 0.410 |
Why?
|
| Adult | 16 | 2025 | 30410 | 0.400 |
Why?
|
| Papillomavirus Infections | 2 | 2020 | 386 | 0.390 |
Why?
|
| Lasers, Gas | 1 | 2012 | 6 | 0.380 |
Why?
|
| Intensive Care Units, Pediatric | 1 | 2016 | 472 | 0.370 |
Why?
|
| Anticoagulants | 1 | 2017 | 581 | 0.370 |
Why?
|
| Speech Therapy | 2 | 2025 | 14 | 0.370 |
Why?
|
| Young Adult | 9 | 2024 | 9665 | 0.370 |
Why?
|
| Nasal Cavity | 1 | 2012 | 55 | 0.360 |
Why?
|
| Time Factors | 7 | 2024 | 6134 | 0.360 |
Why?
|
| Anti-Dyskinesia Agents | 1 | 2011 | 40 | 0.360 |
Why?
|
| Scoliosis | 2 | 2024 | 140 | 0.350 |
Why?
|
| Endoscopy | 3 | 2022 | 280 | 0.350 |
Why?
|
| Reproducibility of Results | 4 | 2024 | 2883 | 0.330 |
Why?
|
| Health Behavior | 1 | 2013 | 385 | 0.330 |
Why?
|
| Diagnosis, Differential | 4 | 2018 | 1861 | 0.330 |
Why?
|
| Botulinum Toxins | 1 | 2011 | 125 | 0.320 |
Why?
|
| Pilot Projects | 3 | 2023 | 1398 | 0.310 |
Why?
|
| Surveys and Questionnaires | 5 | 2024 | 3907 | 0.290 |
Why?
|
| Incidence | 4 | 2025 | 3251 | 0.290 |
Why?
|
| Oxygen | 1 | 2012 | 541 | 0.290 |
Why?
|
| Airway Extubation | 2 | 2020 | 70 | 0.280 |
Why?
|
| Mastoiditis | 1 | 2008 | 33 | 0.280 |
Why?
|
| Sensitivity and Specificity | 3 | 2021 | 2065 | 0.280 |
Why?
|
| Reference Values | 3 | 2016 | 683 | 0.280 |
Why?
|
| Aged, 80 and over | 6 | 2020 | 6668 | 0.270 |
Why?
|
| Health Knowledge, Attitudes, Practice | 1 | 2013 | 880 | 0.260 |
Why?
|
| Injections | 2 | 2017 | 112 | 0.260 |
Why?
|
| Speech-Language Pathology | 2 | 2019 | 13 | 0.260 |
Why?
|
| Anxiety | 1 | 2013 | 964 | 0.260 |
Why?
|
| United States | 7 | 2025 | 11310 | 0.260 |
Why?
|
| Cohort Studies | 3 | 2021 | 4954 | 0.250 |
Why?
|
| Recovery of Function | 3 | 2019 | 439 | 0.240 |
Why?
|
| Otolaryngology | 2 | 2021 | 114 | 0.240 |
Why?
|
| Intubation, Intratracheal | 2 | 2023 | 285 | 0.240 |
Why?
|
| Streptococcus pneumoniae | 1 | 2008 | 377 | 0.240 |
Why?
|
| Aged | 9 | 2025 | 20344 | 0.230 |
Why?
|
| Phonetics | 1 | 2025 | 35 | 0.230 |
Why?
|
| Inpatients | 2 | 2022 | 541 | 0.230 |
Why?
|
| Constriction, Pathologic | 2 | 2023 | 227 | 0.230 |
Why?
|
| Diskectomy | 1 | 2024 | 13 | 0.220 |
Why?
|
| Surgical Stomas | 1 | 2024 | 8 | 0.210 |
Why?
|
| Amyloidosis | 1 | 2025 | 73 | 0.210 |
Why?
|
| Bandages | 1 | 2024 | 54 | 0.210 |
Why?
|
| Confidence Intervals | 2 | 2016 | 261 | 0.210 |
Why?
|
| Severity of Illness Index | 4 | 2024 | 2975 | 0.200 |
Why?
|
| Linear Models | 1 | 2025 | 681 | 0.200 |
Why?
|
| Spinal Fusion | 1 | 2024 | 114 | 0.200 |
Why?
|
| Health Care Surveys | 1 | 2024 | 280 | 0.200 |
Why?
|
| Biopsy | 2 | 2017 | 1236 | 0.200 |
Why?
|
| Chronic Disease | 2 | 2025 | 1194 | 0.200 |
Why?
|
| Vascular Surgical Procedures | 2 | 2018 | 532 | 0.190 |
Why?
|
| Recurrence | 3 | 2021 | 1406 | 0.180 |
Why?
|
| Patient Compliance | 1 | 2025 | 458 | 0.180 |
Why?
|
| Respiration, Artificial | 1 | 2024 | 489 | 0.180 |
Why?
|
| Aerosols | 1 | 2021 | 59 | 0.170 |
Why?
|
| Age Factors | 2 | 2025 | 2789 | 0.170 |
Why?
|
| Drug Resistant Epilepsy | 1 | 2024 | 248 | 0.170 |
Why?
|
| Evaluation Studies as Topic | 1 | 2021 | 238 | 0.170 |
Why?
|
| Leukoplakia | 1 | 2020 | 3 | 0.170 |
Why?
|
| Ethosuximide | 1 | 2020 | 13 | 0.170 |
Why?
|
| Respiratory Tract Neoplasms | 1 | 2020 | 9 | 0.170 |
Why?
|
| Papilloma | 1 | 2020 | 22 | 0.170 |
Why?
|
| Predictive Value of Tests | 2 | 2019 | 2225 | 0.160 |
Why?
|
| Software | 1 | 2025 | 711 | 0.160 |
Why?
|
| Bevacizumab | 1 | 2020 | 53 | 0.160 |
Why?
|
| Publishing | 1 | 2021 | 100 | 0.160 |
Why?
|
| Cricoid Cartilage | 1 | 2020 | 14 | 0.160 |
Why?
|
| Surgical Flaps | 1 | 2022 | 185 | 0.160 |
Why?
|
| Vomiting | 1 | 2020 | 99 | 0.160 |
Why?
|
| Esophagoscopes | 1 | 2019 | 5 | 0.150 |
Why?
|
| Single-Blind Method | 1 | 2019 | 233 | 0.150 |
Why?
|
| Antineoplastic Agents, Immunological | 1 | 2020 | 123 | 0.150 |
Why?
|
| Airway Management | 1 | 2019 | 68 | 0.150 |
Why?
|
| Social Determinants of Health | 1 | 2021 | 148 | 0.150 |
Why?
|
| Neck | 2 | 2017 | 141 | 0.150 |
Why?
|
| Hearing Loss, Unilateral | 1 | 2018 | 9 | 0.150 |
Why?
|
| Periodicals as Topic | 1 | 2021 | 177 | 0.150 |
Why?
|
| Hearing Aids | 1 | 2018 | 31 | 0.140 |
Why?
|
| Prognosis | 4 | 2020 | 4772 | 0.140 |
Why?
|
| Congenital Abnormalities | 1 | 2022 | 300 | 0.140 |
Why?
|
| Esophagoscopy | 1 | 2019 | 164 | 0.140 |
Why?
|
| Standard of Care | 1 | 2018 | 133 | 0.140 |
Why?
|
| Ambulatory Care Facilities | 1 | 2019 | 235 | 0.130 |
Why?
|
| Laryngectomy | 1 | 2017 | 31 | 0.130 |
Why?
|
| Intraoperative Complications | 1 | 2018 | 155 | 0.130 |
Why?
|
| Texas | 2 | 2017 | 3551 | 0.130 |
Why?
|
| Cell Transformation, Neoplastic | 1 | 2020 | 606 | 0.130 |
Why?
|
| Carboxymethylcellulose Sodium | 1 | 2017 | 12 | 0.130 |
Why?
|
| Social Class | 1 | 2018 | 202 | 0.130 |
Why?
|
| Parotid Gland | 1 | 2016 | 17 | 0.130 |
Why?
|
| Pneumonia | 1 | 2020 | 334 | 0.130 |
Why?
|
| Neurosurgical Procedures | 1 | 2019 | 297 | 0.130 |
Why?
|
| Neoplasm Grading | 1 | 2017 | 258 | 0.130 |
Why?
|
| Gastroesophageal Reflux | 1 | 2020 | 323 | 0.130 |
Why?
|
| Risk Factors | 2 | 2024 | 10555 | 0.130 |
Why?
|
| Sound Spectrography | 1 | 2016 | 8 | 0.130 |
Why?
|
| Acoustics | 1 | 2016 | 21 | 0.120 |
Why?
|
| Preoperative Care | 1 | 2018 | 354 | 0.120 |
Why?
|
| Early Medical Intervention | 1 | 2016 | 29 | 0.120 |
Why?
|
| Postoperative Period | 1 | 2016 | 323 | 0.120 |
Why?
|
| Keloid | 1 | 2015 | 11 | 0.120 |
Why?
|
| Self-Assessment | 1 | 2015 | 59 | 0.120 |
Why?
|
| Biomechanical Phenomena | 1 | 2016 | 254 | 0.120 |
Why?
|
| Feeding and Eating Disorders | 1 | 2016 | 73 | 0.110 |
Why?
|
| Patient Care Team | 1 | 2019 | 550 | 0.110 |
Why?
|
| Equipment Design | 2 | 2019 | 575 | 0.110 |
Why?
|
| Length of Stay | 2 | 2018 | 1377 | 0.110 |
Why?
|
| Esophageal Atresia | 1 | 2014 | 51 | 0.100 |
Why?
|
| Patient Safety | 1 | 2018 | 434 | 0.100 |
Why?
|
| Risk Assessment | 2 | 2013 | 3586 | 0.100 |
Why?
|
| Acute Disease | 1 | 2016 | 1135 | 0.100 |
Why?
|
| Office Visits | 1 | 2013 | 78 | 0.100 |
Why?
|
| Health Services Accessibility | 1 | 2018 | 658 | 0.100 |
Why?
|
| Biomarkers, Tumor | 1 | 2020 | 1560 | 0.090 |
Why?
|
| Synkinesis | 1 | 2011 | 2 | 0.090 |
Why?
|
| Vital Signs | 1 | 2012 | 26 | 0.090 |
Why?
|
| Surgical Stapling | 1 | 2011 | 17 | 0.090 |
Why?
|
| Algorithms | 1 | 2018 | 1633 | 0.090 |
Why?
|
| Self Care | 1 | 2013 | 228 | 0.090 |
Why?
|
| Psychometrics | 1 | 2015 | 655 | 0.090 |
Why?
|
| Blood Pressure Determination | 1 | 2012 | 107 | 0.090 |
Why?
|
| Magnetic Resonance Imaging | 2 | 2021 | 3695 | 0.080 |
Why?
|
| Radiography | 1 | 2011 | 752 | 0.080 |
Why?
|
| Disease Progression | 1 | 2015 | 2109 | 0.080 |
Why?
|
| Ambulatory Care | 1 | 2012 | 396 | 0.070 |
Why?
|
| Electrophoresis, Gel, Pulsed-Field | 1 | 2008 | 92 | 0.070 |
Why?
|
| Serotyping | 1 | 2008 | 171 | 0.070 |
Why?
|
| Temporal Bone | 1 | 2008 | 36 | 0.070 |
Why?
|
| Vaccines, Conjugate | 1 | 2008 | 82 | 0.070 |
Why?
|
| Hemodynamics | 1 | 2012 | 822 | 0.070 |
Why?
|
| Pneumococcal Vaccines | 1 | 2008 | 174 | 0.060 |
Why?
|
| Lactoferrin | 1 | 2007 | 76 | 0.060 |
Why?
|
| Pneumococcal Infections | 1 | 2008 | 276 | 0.060 |
Why?
|
| Drug Resistance, Bacterial | 1 | 2008 | 381 | 0.060 |
Why?
|
| Microbial Sensitivity Tests | 1 | 2008 | 815 | 0.060 |
Why?
|
| Silver | 1 | 2024 | 27 | 0.050 |
Why?
|
| Atrophy | 1 | 2025 | 237 | 0.050 |
Why?
|
| Breathing Exercises | 1 | 2022 | 8 | 0.050 |
Why?
|
| Biofeedback, Psychology | 1 | 2022 | 38 | 0.050 |
Why?
|
| Surgical Wound Infection | 1 | 2024 | 263 | 0.050 |
Why?
|
| Hoarseness | 1 | 2021 | 12 | 0.050 |
Why?
|
| Head and Neck Neoplasms | 1 | 2007 | 589 | 0.040 |
Why?
|
| Hearing Loss, Bilateral | 1 | 2021 | 16 | 0.040 |
Why?
|
| Carcinoma, Squamous Cell | 1 | 2007 | 744 | 0.040 |
Why?
|
| Poly A | 1 | 2001 | 46 | 0.040 |
Why?
|
| Xenopus | 1 | 2001 | 103 | 0.040 |
Why?
|
| Xenopus Proteins | 1 | 2001 | 59 | 0.040 |
Why?
|
| Wound Healing | 1 | 2024 | 447 | 0.040 |
Why?
|
| Cross-Sectional Studies | 2 | 2020 | 3662 | 0.040 |
Why?
|
| Patient Reported Outcome Measures | 1 | 2022 | 203 | 0.040 |
Why?
|
| Delphi Technique | 1 | 2021 | 240 | 0.040 |
Why?
|
| Body Height | 1 | 2020 | 191 | 0.040 |
Why?
|
| Organ Size | 1 | 2020 | 429 | 0.040 |
Why?
|
| Hearing | 1 | 2018 | 61 | 0.040 |
Why?
|
| Language Development | 1 | 2018 | 36 | 0.040 |
Why?
|
| Sex Characteristics | 1 | 2020 | 311 | 0.040 |
Why?
|
| T-Lymphocytes | 1 | 2007 | 1705 | 0.040 |
Why?
|
| Insurance, Health | 1 | 2018 | 134 | 0.030 |
Why?
|
| Antineoplastic Agents | 1 | 2007 | 1758 | 0.030 |
Why?
|
| Language Development Disorders | 1 | 2018 | 177 | 0.030 |
Why?
|
| RNA-Binding Proteins | 1 | 2001 | 533 | 0.030 |
Why?
|
| Feeding Methods | 1 | 2016 | 35 | 0.030 |
Why?
|
| Triamcinolone Acetonide | 1 | 2015 | 19 | 0.030 |
Why?
|
| Head | 1 | 2015 | 108 | 0.030 |
Why?
|
| Health Care Costs | 1 | 2018 | 392 | 0.030 |
Why?
|
| Self Concept | 1 | 2015 | 155 | 0.030 |
Why?
|
| Body Mass Index | 1 | 2020 | 1654 | 0.030 |
Why?
|
| Healthcare Disparities | 1 | 2018 | 482 | 0.030 |
Why?
|
| Logistic Models | 1 | 2018 | 1779 | 0.030 |
Why?
|
| Anti-Inflammatory Agents | 1 | 2015 | 288 | 0.020 |
Why?
|
| Recombinant Proteins | 2 | 2007 | 1293 | 0.020 |
Why?
|
| Cyclin D1 | 1 | 2007 | 108 | 0.020 |
Why?
|
| Administration, Oral | 1 | 2007 | 669 | 0.010 |
Why?
|
| Flow Cytometry | 1 | 2007 | 754 | 0.010 |
Why?
|
| Immunohistochemistry | 1 | 2007 | 1597 | 0.010 |
Why?
|
| Precipitin Tests | 1 | 2001 | 136 | 0.010 |
Why?
|
| Poly(A)-Binding Proteins | 1 | 2001 | 23 | 0.010 |
Why?
|
| Cytokines | 1 | 2007 | 1320 | 0.010 |
Why?
|
| Adenosine Monophosphate | 1 | 2001 | 47 | 0.010 |
Why?
|
| Ultraviolet Rays | 1 | 2001 | 191 | 0.010 |
Why?
|
| Sequence Homology, Amino Acid | 1 | 2001 | 622 | 0.010 |
Why?
|
| Plasmids | 1 | 2001 | 445 | 0.010 |
Why?
|
| Cell Proliferation | 1 | 2007 | 2397 | 0.010 |
Why?
|
| Cell Line, Tumor | 1 | 2007 | 3498 | 0.010 |
Why?
|
| Transcriptional Activation | 1 | 2001 | 412 | 0.010 |
Why?
|
| Oocytes | 1 | 2001 | 280 | 0.010 |
Why?
|
| Kinetics | 1 | 2001 | 1090 | 0.010 |
Why?
|
| Blotting, Western | 1 | 2001 | 1014 | 0.010 |
Why?
|
| Protein Binding | 1 | 2001 | 1661 | 0.010 |
Why?
|
| Amino Acid Sequence | 1 | 2001 | 2541 | 0.010 |
Why?
|
| Base Sequence | 1 | 2001 | 2757 | 0.010 |
Why?
|
| Gene Expression Regulation, Developmental | 1 | 2001 | 968 | 0.010 |
Why?
|
| Molecular Sequence Data | 1 | 2001 | 3584 | 0.010 |
Why?
|
| Sequence Analysis, DNA | 1 | 2001 | 1707 | 0.010 |
Why?
|
| DNA Methylation | 1 | 2001 | 1025 | 0.010 |
Why?
|
| Animals | 2 | 2007 | 33051 | 0.010 |
Why?
|
| Mice | 1 | 2007 | 17596 | 0.010 |
Why?
|